Skip to main content
. Author manuscript; available in PMC: 2016 Feb 19.
Published in final edited form as: Chem Biol. 2015 Jan 22;22(2):285–292. doi: 10.1016/j.chembiol.2014.10.023

Figure 3.

Figure 3

Comparison of implant P24 levels, T-lymphocytes and HIV-1 RNA in the SCID-hu Thy/Liv mouse model, following bi-daily doses of either 50 or 100 mg.kg−1 alisporivir (ALV) or NVP018 for two weeks. *=p≤0.05, compared with untreated mice